TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.

about

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.

Item

http://www.wikidata.org/entity/Q50088569

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@en

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@nl

type

Item

label

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@en

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@nl

prefLabel

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@en

TPF plus cetuximab induction c ...... ndomized phase II EORTC trial.

@nl

P1476

TPF plus cetuximab induction c ...... andomized phase II EORTC trial

@en

P2093

A Awada

http://www.w3.org/2001/XMLSchema#string

C Bergamini

http://www.w3.org/2001/XMLSchema#string

C Fortpied

http://www.w3.org/2001/XMLSchema#string

D L Schrijvers

http://www.w3.org/2001/XMLSchema#string

E Remenar

http://www.w3.org/2001/XMLSchema#string

J B Vermorken

http://www.w3.org/2001/XMLSchema#string

J Buter

http://www.w3.org/2001/XMLSchema#string

L F Licitra

http://www.w3.org/2001/XMLSchema#string

P M Clement

http://www.w3.org/2001/XMLSchema#string

P M Specenier

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.

Helical tomotherapy in head and neck cancer: a European single-center experience.

A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer

P304

2219-2224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX300

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jessica Menis

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28911062

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

phase II clinical trial